1. Novartis strikes deal with UK to provide cholesterol drug to high-risk patients  CNBC
  2. UK’s NHS teams with Novartis to launch heart attack drug trial  Financial Times
  3. NHS to trial twice-yearly injection alternative to statins  The Guardian
  4. Heart jab which can halve bad cholesterol in two weeks gets NHS green light  The Telegraph
  5. 'Game-changing' heart disease drug 'could save 30,000 lives' over the next decade  Mirror Online
  6. View full coverage on Google News
The Swiss drugmaker will provide the drug to patients with atherosclerosis, a heart disease in which plaque builds up inside arteries and can lead to problems, including heart attack or death.The Swiss drugmaker will provide the drug to patients with atherosclerosis, a heart disease in which plaque builds up inside arteries and can lead to problems, including heart attack or death.

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

The deal will make the Phase III drug inclisiran - which Novartis acquired when it bought The Medicines Company in November - available to patients in the U.K. and include manufacturing and clinical development efforts. The deal will make the Phase III drug inclisiran - which Novartis acquired when it bought The Medicines Company in November - available to patients in the U.K. and include manufacturing and clinical development efforts.

Novartis, UK's NHS form population health partnership around new cholesterol drug - MedCity News

Patients should soon have access to a new cholesterol-lowering treatment for preventing heart attacks and strokes as Government plans for it to become widely available on the NHS Patients should soon have access to a new cholesterol-lowering treatment for preventing heart attacks and strokes as Government plans for it to become widely available on the NHS

'Game-changing' heart disease drug 'could save 30,000 lives' over the next decade - Mirror Online

A jab which is more powerful than statins has been given the go-ahead by the NHS, in a bid to prevent 30,000 deaths from heart attacks and strokes.A jab which is more powerful than statins has been given the go-ahead by the NHS, in a bid to prevent 30,000 deaths from heart attacks and strokes.

Heart jab which can halve bad cholesterol in two weeks gets NHS green light